Browse > Article

Enhancement of Antigen-specific Antibody and $CD8^+$ T Cell Responses by Codelivery of IL-12-encapsulated Microspheres in Protein and Peptide Vaccination  

Park, Su-Hyung (Division of Molecular and Life Sciences, Postech Biotech Center, Pohang University of Science & Technology)
Chang, Jun (College of Pharmacy, Ewha Womans University)
Yang, Se-Hwan (Division of Molecular and Life Sciences, Postech Biotech Center, Pohang University of Science & Technology)
Kim, Hye-Ju (Division of Molecular and Life Sciences, Postech Biotech Center, Pohang University of Science & Technology)
Kwak, Hyun-Hee (Research Laboratories, Dong-A Pham. Co., Ltd.)
Kim, Byong-Moon (Research Laboratories, Dong-A Pham. Co., Ltd.)
Lee, Sung-Hee (Research Laboratories, Dong-A Pham. Co., Ltd.)
Sung, Young-Chul (Division of Molecular and Life Sciences, Postech Biotech Center, Pohang University of Science & Technology)
Publication Information
IMMUNE NETWORK / v.7, no.4, 2007 , pp. 186-196 More about this Journal
Abstract
Background: Although IL-12 has been widely accepted to playa central role in the control of pathogen infection, the use of recombinant IL-12 (rIL-12) as a vaccine adjuvant has been known to be ineffective because of its rapid clearance in the body. Methods: To investigate the effect of sustained release of IL-12 in vivo in the peptide and protein vaccination models, rIL-12 was encapsulated into poly ($A_{DL}$-lactic-co-glycolic acid) (PLGA). Results: We found that codelivery of IL-12-encapsulated microspheres (IL-12EM) could dramatically increase not only antibody responses, but also antigen-specific $CD4^+\;and\;CD8^+$ T cell responses. Enhanced immune responses were shown to be correlated with protective immunity against influenza and respiratory syncytial virus (RSV) virus challenge. Interestingly, the enhancement of $CD8^+$ T cell response was not detectable when $CD4^+$ T cell knockout mice were subjected to vaccination, indicating that the enhancement of the $CD8^+$ T cell response by IL-12EM is dependent on $CD4^+$ T cell "help". Conclusion: Thus, IL-12EM could be applied as an adjuvant of protein and peptide vaccines to enhance protective immunity against virus infection.
Keywords
Interleukin 12; PLGA microspheres; vaccine adjuvant; CTL response;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Crotts G, Park TG: Protein delivery from poly (lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J Microencapsul 15;699-713, 1998   DOI
2 Datta SK, Redecke V, Prilliman KR, Takabayashi K, Corr M, Tallant T, DiDonato J, Dziarski R, Akira S, Schoenberger SP, Raz E: A subset of Toll-like receptor ligands induces crosspresentation by bone marrow-derived dendritic cells. J Immunol 170;4102-4110, 2003   DOI   PUBMED
3 Egilmez NK, Jong YS, Sabel MS, Jacob JS, Mathiowitz E, Bankert RB: In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity. Cancer Res 60;3832-3837, 2000   PUBMED
4 Ha SJ, Park SH, Kim HJ, Kim SC, Kang HJ, Lee EG, Kwon SG, Kim BM, Lee SH, Kim WB, Sung YC, Cho SN: Enhanced immunogenicity and protective efficacy with the use of interleukin-12-encapsulated microspheres plus AS01B in tuberculosis subunit vaccination. Infect Immun 74;4954-4959, 2006   DOI   ScienceOn
5 Langer R: Drug delivery and targeting. Nature 392;5-10, 1998   PUBMED
6 Lee SW, Youn JW, Seong BL, Sung YC: IL-6 induces longterm protective immunity against a lethal challenge of influenza virus. Vaccine 17;490-496, 1999   DOI   ScienceOn
7 Machy P, Serre K, Leserman L: Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells. Eur J Immunol 30;848-857, 2000   DOI   ScienceOn
8 Partidos CD, Vohra P, Jones D, Farrar G, Steward MW: CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles. J Immunol Methods 206;143-151, 1997   DOI   ScienceOn
9 Stuhler G, Schlossman SF: Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets. Proc Natl Acad Sci U S A 94;622-627, 1997
10 Knutson KL, Schiffman K, Disis ML: Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients. J Clin Invest 107;477-484, 2001   DOI   ScienceOn
11 Park SH, Yang SH, Lee CG, Youn JW, Chang J, Sung YC: Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost. Vaccine 21;4555-4564, 2003   DOI   ScienceOn
12 Fayolle C, Deriaud E, Leclerc C: In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help. J Immunol 147;4069-4073, 1991   PUBMED
13 Guerder S, Matzinger P: A fail-safe mechanism for maintaining self-tolerance. J Exp Med 176;553-564, 1992   DOI   ScienceOn
14 Ha SJ, Chang J, Song MK, Suh YS, Jin HT, Lee CH, Nam GH, Choi G, Choi KY, Lee SH, Kim WB, Sung YC: Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization. Nat Biotechnol 20;381-386, 2002   DOI   ScienceOn
15 Berzofsky JA, Ahlers JD, Belyakov IM: Strategies for designing and optimizing new generation vaccines. Nat Rev Immunol 1;209-219, 2001   DOI   ScienceOn
16 Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177;1505-1509, 1993   DOI
17 Yap G, Pesin M, Sher A: Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J Immunol 165;628-631, 2000   DOI
18 Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P: The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263;235-237, 1994   DOI
19 den Haan JM, Bevan MJ: Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(+) dendritic cells in vivo. J Exp Med 196;817-827, 2002   DOI
20 Putney SD, Burke PA: Improving protein therapeutics with sustained-release formulations. Nat Biotechnol 16;153-157, 1998   DOI   ScienceOn
21 Gurunathan S, Prussin C, Sacks DL, Seder RA: Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat Med 4;1409-1415, 1998   DOI   ScienceOn
22 Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR: Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 186;65-70, 1997   DOI
23 Curtsinger JM, Schmidt CS, Mondino A, Lins DC, Kedl RM, Jenkins MK, Mescher MF: Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol 162;3256-3262, 1999   PUBMED
24 Song K, Chang Y, Prud'homme GJ: IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice. Gene Ther 7;1527-1535, 2000   DOI
25 Athie-Morales V, Smits HH, Cantrell DA, Hilkens CM: Sustained IL-12 signaling is required for Th1 development. J Immunol 172;61-69, 2004   DOI   PUBMED
26 Kurts C, Carbone FR, Barnden M, Blanas E, Allison J, Heath WR, Miller JF: CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 186;2057-2062, 1997   DOI
27 Kubin M, Chow JM, Trinchieri G: Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83;1847-1855, 1994
28 Lindblad EB, Elhay MJ, Silva R, Appelberg R, Andersen P: Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect Immun 65;623-629, 1997   PUBMED
29 Vogel LA, Showe LC, Lester TL, McNutt RM, Van Cleave VH, Metzger DW: Direct binding of IL-12 to human and murine B lymphocytes. Int Immunol 8;1955-1962, 1996   DOI
30 Hamajima K, Fukushima J, Bukawa H, Kaneko T, Tsuji T, Asakura Y, Sasaki S, Xin KQ, Okuda K: Strong augment effect of IL-12 expression plasmid on the induction of HIVspecific cytotoxic T lymphocyte activity by a peptide vaccine candidate. Clin Immunol Immunopathol 83;179-184, 1997   DOI   ScienceOn
31 Kim TH, Park TG: Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres. Int J Pharm 271;207-214, 2004   DOI   ScienceOn
32 Langer R: Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc Chem Res 33;94-101, 2000   DOI   ScienceOn
33 Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ: T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393;480-483, 1998   DOI   ScienceOn
34 Youn JW, Park SH, Lavillette D, Cosset FL, Yang SH, Lee CG, Jin HT, Kim CM, Shata MT, Lee DH, Pfahler W, Prince AM, Sung YC: Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee. Hepatology 42;1429-1436, 2005   DOI   ScienceOn
35 Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM: Phenotypic analysis of antigen-specific T lymphocytes. Science 274;94-96, 1996   DOI   ScienceOn
36 Haskova Z, Usiu N, Pepose JS, Ferguson TA, Stuart PM: CD4+ T cells are critical for corneal, but not skin, allograft rejection. Transplantation 69;483-487, 2000   DOI   ScienceOn
37 Bliss J, Van Cleave V, Murray K, Wiencis A, Ketchum M, Maylor R, Haire T, Resmini C, Abbas AK, Wolf SF: IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J Immunol 156;887-894, 1996   PUBMED
38 Kyburz D, Aichele P, Speiser DE, Hengartner H, Zinkernagel RM, Pircher H: T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol 23;1956-1962, 1993   DOI   ScienceOn
39 Serre K, Giraudo L, Siret C, Leserman L, Machy P: CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo. Eur J Immunol 36;1386-1397, 2006   DOI   ScienceOn
40 Machy P, Serre K, Baillet M, Leserman L: Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains. J Immunol 168;1172-1180, 2002   DOI   PUBMED
41 Wild J, Grusby MJ, Schirmbeck R, Reimann J: Priming MHCI-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. J Immunol 163;1880-1887, 1999   PUBMED
42 Hill HC, Conway TF Jr, Sabel MS, Jong YS, Mathiowitz E, Bankert RB, Egilmez NK: Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Cancer Res 62;7254-7263, 2002   PUBMED
43 Chang J, Choi SY, Jin HT, Sung YC, Braciale TJ: Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection. J Immunol 172;503-508, 2004   DOI   PUBMED
44 Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G: The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 183;147-157, 1996   DOI